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In Response: Dr Kittelberger 
comments on our recent report of 
2 cows in Switzerland that were 
classifi ed as positive for bovine 
spongiform encephalopathy (BSE), 
according to the established criteria 
(1,2). He raises concerns that the 
unusual prion protein signature in 
Western blot (WB) in these cows 
represents a physiologic prion protein 
(PrPC) fragment, ineffi ciently degraded 
by proteinase K (PK), termed C1. 
Certainly the effects of tissue autolysis 
on PK activity and the molecular prion 
protein signature are of particular 
concern and deserve full consideration 
in data interpretation. In our study, 
molecular mass comparisons between 
PrPC in non-PK–treated brain tissue 
of healthy cattle and the prion protein 
in samples from the 2 aberrant cows 
with BSE in WB were considerably 
hindered by overlapping C1- and 
full-length PrPC bands in the non-PK–
treated samples and did not allow for 
a robust conclusion (T. Seuberlich, 
unpub. data). It is noteworthy that the 
Prionics Check WESTERN (Prionics, 
Zurich, Switzerland) test has been 
extensively validated in terms of 
the diagnostic specifi city, also on 
severely autolytic specimens (3–5). 
In none of these studies was a similar 
prion protein signature observed. We 
therefore considered it unlikely that the 
fi ndings in the cases from Switzerland 
resulted from tissue autolysis.
Dr Kittelberger provides data 
from New Zealand cattle that revealed 
a similar prion protein signature in 
WB. He assumes that these animals 
had a negative BSE status and that the 
PK digestion in the WB did not work 
properly, which is supported by results 
from other diagnostic techniques. 
However, information about the 
degree of autolysis of these samples 
is missing, and, most notably, whether 
these fi ndings are correlated with prion 
infectivity is not known. Strikingly, in 
contrast to the results for the samples 
from Switzerland, the samples 
from New Zealand are reported to 
be negative in the Prionics Check 
WESTERN. It would be fascinating to 
perform a side-by-side analysis of the 
samples from Switzerland and from 
New Zealand to determine whether the 
banding characteristics in both groups 
are identical. Studies are under way in 
our laboratory to further investigate 
the effect of tissue autolysis on PK 
activity and PrPC degradation under 
experimental conditions. If our 
fi ndings turn out to be the result of 
inhibited PK activity in BSE-negative 
cattle samples, the current diagnostic 
criteria might require revision. As long 
as the results of these experiments and 
the ongoing transmission studies are 
not available, we can neither confi rm 
nor reject a novel type of BSE.
Torsten Seuberlich
Author affi liation: University of Berne, 
Berne, Switzerland
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Correction, Vol. 18 No. 1
Author Henry J.C. de Vries’ initials were listed incor-
rectly in Cutaneous Leishmaniasis Acquired in Jura, France 
(W.R. Faber et al.). The article has been corrected online 
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Author Richard Njouom’s surname was misspelled in High 
Seroprevalence of Enterovirus Infections in Apes and Old 
World Monkeys (H. Harvala et al.). The article has been 
corrected online (wwwnc.cdc.gov/eid/article/18/2/11-1363_
article.htm).
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